We investigated the antimicrobial resistance in gonococci 2009-2014 in Yaoundé, Cameroon, and recommend revisions of the Cameroonian treatment guideline. We observed a high resistance to ciprofloxacin (17.6%) but no ceftriaxone resistance. Ceftriaxone should replace ciprofloxacin as the recommended first-line treatment for urethral/vaginal discharge. Enhanced resistance surveillance in Africa is essential.
Funding Agencies:
Centre Pasteur of Cameroon, Yaounde, Cameroon
Department of Reproductive Health and Research, World Health Organization, Geneva